Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study
Authors
Marcus Cumberbatch (ORCID: https://orcid.org/0000-0001-5548-379X)
Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study
Marcus Cumberbatch, Alastair Lamb, Samuel G. Smith, Peter David Sasieni et al.
Citations
2 citations
Journal
BMJ Open
Topics
Prostate Cancer Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
3.04
article
Protocol for a randomised phase 3 trial evaluating the role of Finasteride in Active Surveillance for men with low and intermediate-risk prostate cancer: the FINESSE Study
Marcus Cumberbatch, Alastair Lamb, Samuel G. Smith, Peter David Sasieni, James W.F. Catto, William Cross, Bernard V. North, Roseann Kealy, Richard J. Bryant, Steven Kennish, Rachel Hubbard, Simon Faulkner, Rohit Chahal, Mohantha Dooldeniya, S Bhattrai
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
University of Leeds (GB), Queen Mary University of London (GB), Leeds Teaching Hospitals NHS Trust (GB), Churchill Hospital (GB), University of Oxford (GB), Sheffield Teaching Hospitals NHS Foundation Trust (GB), Mid Yorkshire Hospitals NHS Trust (GB), Bradford Teaching Hospitals NHS Foundation Trust (GB), University of Sheffield (GB)
Funders
Queen Mary University of London, Cancer Research UK, National Institute for Health and Care Research, Department of Health and Social Care, Sheffield Teaching Hospitals NHS Foundation Trust